Johnson & Johnson

2 Articles

Participants follow proceedings during the launch of Paliperidone Palmitate for the treatment of schizophrenia. It will be used by adults whose disease has already been stabilized on treatment with paliperidone or risperidone. www.businesstoday.co.ke

Good News: Schizophrenia Medication Approved in Kenya

The new drug works as a receptor antagonist of dopamine and serotonin, leading to the stabilization of these two chemicals in the brain.

Govt partners with Johnson & Johnson on cancer control

The National Cancer Control Strategy 2017-2022 is geared at reducing cancer incidences, morbidity and mortality in Kenya

BT Correspondent

© Copyright 2024. Business Today. All rights reserved